Delivery Order SPE2DB24D2101-SPE2DB25FKPYG
Award Date 9/24/25
Potential Completion Date 10/16/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,151.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on August 15, 2025, for the supply of Imbruvica 280 mg tablets (quantity: 28 units) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The order is non-set-aside and competitively awarded, with an ultimate completion date of September 8, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28 count) on June 6, 2025, with completion targeted for June 30, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,575.75 for IMBRUVICA 140 mg tablets (28-count supply) on August 28, 2025, with completion scheduled for September 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- This delivery order, awarded on September 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, covers the supply of Imbruvica 420 mg tablets (28-count) with a firm fixed price ceiling value of $15,151.52 and an ultimate completion date of October 15, 2025. The contract is unclassified as a set-aside procurement, indicating it was competitively awarded to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...